Congress Explores Plans For Catching Up On US FDA Foreign Inspections

Absent agency said to have a plan to overcome vacancies and clear inspection backlog; subcommittee has other plans.

Capitol Building, Washington DC
GAO aims to give its assessment of FDA's plan by May.

The US Food and Drug Administration has a plan to overcome staffing challenges and catch up on backlogged foreign inspections in the wake of the COVID-19 pandemic, a congressional audit agency told a House Energy and Commerce subcommittee during a 6 February hearing on the agency’s foreign inspection program.

But no one from the FDA was there to talk about the plan; the oversight and investigations committee’s chair, Rep....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Compliance